SCHEMBL14219071

SCHEMBL14219071

CN(C)S(=O)(=O)c1cc(Nc2cc(C3CCCN(C(=O)OC(C)(C)C)C3)nc3c(-c4cn[nH]c4)cnn23)ccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 6/20 0.41
▸ CDK2 P24941 3/20 0.39
▸ GSK3B P49841 3/20 0.39
▸ JAK1 P23458 1/20 0.36
▸ GPR119 Q8TDV5 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ ROCK2 O75116 2/20 0.36
▸ GPR35 Q9HC97 2/20 0.36
▸ GPR55 Q9Y2T6 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11931564 0.91 CHEK1 (0.49) CHEK1CDK2
SCHEMBL14219070 0.89 CHEK1 (0.40) CHEK1CDK2GSK3BJAK1GPR119
SCHEMBL14219069 0.86 CHEK1 (0.44) CHEK1JAK1GPR119PIK3CAROCK2
SCHEMBL14218632 0.85 CHEK1 (0.45) CHEK1JAK1GPR119PIK3CAROCK2
SCHEMBL14219068 0.84 JAK2 (0.43) CHEK1JAK1GPR119PIK3CAROCK2
SCHEMBL14218794 0.84 CHEK1 (0.55) CHEK1CDK2GSK3B
SCHEMBL14218631 0.83 CHEK1 (0.43) CHEK1JAK1GPR119PIK3CAROCK2
SCHEMBL14219067 0.83 CHEK1 (0.55) CHEK1CDK2JAK1GPR119PIK3CA
SCHEMBL11931560 0.82 CHEK1 (0.53) CHEK1CDK2GSK3B
SCHEMBL14232556 0.82 CHEK1 (0.47) CHEK1JAK1GPR119PIK3CAROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008045268-A2 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-04-17 — — WO disclosed
Send feedback